KOSPI Surges 1.5% in Early Trading... Recovers to 2120 Level

Strong Buying by Individuals and Foreigners... KOSDAQ Recovers to 740 Level

Photo by Getty Images Bank

[Asia Economy Reporter Minwoo Lee] The KOSPI recovered to the 2120 level, rising about 1.5% in early trading. It appears that buying pressure from foreigners and individuals drove the index in the early session.

On the 30th, as of 9:15 a.m., the KOSPI recorded 2120.66, up 1.30% (27.18 points) from the previous close. It opened at 2093.48, the same as the previous day's closing price, and has been rising since the early session.

In the securities market, foreigners and individuals net bought 26.7 billion KRW and 69.8 billion KRW, respectively. Meanwhile, institutions net sold 84.5 billion KRW.

All sectors are on the rise. The largest gains were seen in Medical Precision (2.73%), Electric & Electronics (2.30%), and Textiles & Apparel (2.12%). Following were Chemicals (1.79%), Manufacturing (1.69%), and Securities (1.51%).

Most of the top 10 stocks by market capitalization also showed gains. SK Hynix had the largest increase at 3.1%, followed by Samsung Electronics (1.9%), LG Chem (1.5%), Samsung SDI (1.2%), and Hyundai Motor (0.9%). Samsung Biologics fell by 0.5%.

At the same time, the KOSDAQ rose 0.94% (6.87 points) from the previous close to 741.56. It started at 744.54, up 1.34% (9.85 points) from the previous day, then showed a slight decline.

In the KOSDAQ market, foreigners and institutions net bought 1.8 billion KRW and 0.8 billion KRW, respectively. Conversely, individuals net sold 1.7 billion KRW.

Almost all sectors are also on the rise. Non-metallics showed the largest gain at 2.75%, followed by Semiconductors (1.19%), Food & Tobacco (2.03%), IT Hardware (1.96%), and IT Components (1.85%). Other Manufacturing was the only sector to fall, down 0.63%.

The top 10 stocks by market capitalization mostly showed upward trends. Alteogen rose the most at 4.3%, followed by EcoPro BM (1.6%) and CJ ENM (0.9%). On the other hand, HLB (-2.6%), Seegene (-0.9%), and Pearl Abyss (-0.7%) declined. Celltrion Pharm showed no change.